InfuSystem Holdings Inc Stock News

InfuSystem Holdings Inc. (NYSEAMERICAN:INFU) Director Gregg Owen Lehman sold 1,292 shares of the businesss stock in a transaction on Tuesday, November 30th. The stock was sold at an average price of $17.03, for a total transaction of $22,002.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available []

InfuSystem Holdings Inc. (NYSEAMERICAN:INFU) Director Christopher R. Sansone sold 80,000 shares of the firms stock in a transaction on Monday, November 22nd. The shares were sold at an average price of $17.73, for a total transaction of $1,418,400.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. []

Weather Cooling Down, But InfuSystem Heating Up

InfuSystem (NYSEAMERICAN:INFU) released its quarterly earnings results on Monday. The medical instruments supplier reported ($0.02) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.03 by ($0.05), MarketWatch Earnings reports. InfuSystem had a net margin of 15.22% and a return on equity of 38.26%. InfuSystem updated its FY 2021 guidance to EPS. Shares […]

InfuSystem Holdings Inc. (INFU) CEO Richard DiIorio on Q3 2021 Results - Earnings Call Transcript

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem reports third quarter financial results, reaffirms 2021 guidance

Key Players Covered in the Home Infusion Therapy Market Research Report are Optum, Inc., Infusystem, Option Care Health Inc., Moog Inc., CareCentrix, Inc., B. Braun Melsungen AG, Lincare Holdings Inc., Baxter, Promptcare, BriovaRx Infusion Services and other key market players. Key Players Covered in the Home Infusion Therapy Market Research Report are Optum, Inc., Infusystem, Option Care Health Inc., Moog Inc., CareCentrix, Inc., B. Braun Melsungen AG, Lincare Holdings Inc., Baxter, Promptcare, BriovaRx Infusion Services and other key market players.

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to report third quarter 2021 financial results on November 15, 2021

Rochester Hills, Michigan, Sept. 08, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider,

InfuSystem: Looking Beyond The Headline Numbers

InfuSystem Holdings Inc. (INFU) CEO Rich DiIorio on Q2 2021 Results - Earnings Call Transcript

InfuSystems Holdings, Inc. (INFU) delivered earnings and revenue surprises of -63.64% and -9.70%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the st

Launched Fourth ITS Therapy - Lymphedema Announced $20 million Stock Repurchase Program Updates Guidance for 2021

Investor Conference Call to be held 9:00 a.m. Eastern Time Investor Conference Call to be held 9:00 a.m. Eastern Time

InfuSystems Holdings, Inc. (INFU) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further st